top of page

Digital Pathology and Artificial Intelligence:
Next Generation of Pathology for Diagnosis and Research

Industry Leading Accuracy

Clinical Decision Support

Custom Tailored Models

Seamless Integration

Products and Services

Partnership

Flexlis: an integrated LIS, IMS and AI

  • Flexlis LIS: a user-friendly digital pathology reporting system which can be integrated with IMS and AI.

  • Flexlis IMS: a digital pathology software offers state-of-art image management system for categorizing, annotating and viewing histopathology images

  • NovinoAI DX: an AI platform enables cancer detection, prognosis and prediction based on whole slide images.

Laboratory

Laboratory Services

  • NovinoPath: a pathology laboratory accredited by CLIA provides full diagnostic pathology services including histology, immunohistochemistry, fluorescence in situ hybridization, digital PCR, etc.

  • NovinoPath offers research services including tissue processing, slide digitization, image analysis, etc.

  • To visit NovinoPath click this link

Scientist Using Microscope

Technology Capabilities

  • NovinoAI: a software company specializing in the healthcare space provides consultation and development of AI-based software, including cancer diagnosis, prognosis and prediction.

  • Flexoptik scanner: NovinoAI in partner with Flexoptik offers low cost high quality scanners.

Servers

Clinical and Research Partnerships

  • NovinoAI offers digital pathology IMS and AI models for clinical applications

  • NovinoAI's IMS and AI models enhance the research capability for biomarker development and drug discovery. 

  • NovinoAI partners with pathology laboratories, academic institutions, and pharmaceutical  and biotechnology companies.

Features of NovinoAI Digital Pathology 

Open platform and easy to implement

  • Flexlis is an AI assisted and cloud-based system which is turn-key ready and plug-in;

  • Open platform and compatible with most digital slide scanners;

  • Scalable to fit all-size laboratories.

  • Highly secured and regulatorily complained. 

  • AI-assisted quality control of images.

  • Patent pending

Pathologist centered and user friendly

  • Access remotely and securely via website; easy and friendly user experience;

  • Viewing images and the slide labels at high quality and speed; 

  • Ability to have multiple viewer windows open to simultaneously compare different images or stains;

  • Performing annotation and capture of the images easily; 

  • Enable to track, sort and retrieve images and cases; 

  • Ability to share the images among different viewers or pathologists; 

  • Automatically arranging slide images in an usual slide tray format with sequential order of the images.

Artificial intelligence readiness

  • Ready to incorporate various AI modules;

  • Diseases and cancer diagnostic AI modules in development;

  • Research and collaboration in biomarker discovery.

Benefits of FlexLIS IMS

  • Low entry cost, and no local storage server and maintenance needed;

  • Fully supported by FlexLIS team, including training;

  • Improving the workflow, reducing the staff’s time;

  • Immediate availability of images for pathologists to review.

  • Low cost but high quality Flexoptik scanners is available through NovinoAI partners

Implementation of digital pathology

  • NovinoAI team will provide consultation and full support to implement digital pathology into the practices 

  • Factors to be considered:

    • Workflow assessment.

    • Specimen type and volume

    • Number of slides

    • Number of users and locations

    • Space and laboratory staff

Features of NovinoAI Artificial Intelligence

What is Pathology Artificial Intelligence

  • Artificial intelligence (AI) refers to the simulation of human intelligence in computer systems, enabling them to replicate human-like thinking processes and behaviors such as learning and problem-solving. 

  • Application of AI algorithms in computational pathology, Pathology AI, became possible due to the widespread and adaptation of digital pathology.

  • Various approaches can be employed in this domain, including fully supervised learning, unsupervised learning, and weakly supervised learning. 

  • Computational and AI pathology offers great potential in diagnosis, research and biomarker discovery.

NovinoAI platform

  • The pathology AI platform developed by the NovinoAI team is to be used in images of histology slides.

  • The platform is very versatile and flexible in developing AI algorithms based on histology images.  

  • The platform can be used for developing AI algorithms for disease diagnosis and treatment, biomarker discovery and validation, etc.

  • AI algorithms developed by NovinoAI team is an open platform that can be used in any image management system, including Image Management System.

Research and collaboration opportunities

  • NovinoAI provides digital pathology services to researchers and tissue banks including digitizing slides, categorizing images, and supporting collaboration.

  • NovinoAI provides data analysis, artificial intelligence and computation consultation.

  • NovinoAI collaborates with researchers from major academic medical institutions to address clinical question and to identify the solutions

  • NovinoAI supports pharma and biotech collaboration in biomarkers and drug discovery and validation

  • NovinoAI provides support for clinical trials by standardizing pathology services, including interpretation and quality controls.

Cui M and Zhang D. Artificial intelligence and computational pathology. Lab Invest 2021 Apr;101(4):412-422. https://pubmed.ncbi.nlm.nih.gov/33454724/

Zhang D. et al. Implantation of Digital Pathology and Artificial Intelligence in Routine Pathology Practice. Lab Invest . 2024 Jul 23: https://pubmed.ncbi.nlm.nih.gov/39053633/ 

Zhu M et al. Artificial intelligence in pathologic diagnosis, prognosis and prediction of prostate cancer. Am J Clin Exp Urol. 2024 Aug 25;12(4):200-215

shutterstock_1986623069.jpeg

About NovinoAI

  • NovinoAI is a software company focused on the development of AI assisted software in the healthcare space.

  • NovinoAI is a leading company developing pathology image management system (IMS) and AI models for routine clinical use.

  • FlexLIS IMS supports pathology laboratories to streamline the process of review, interpretation and diagnosis.

  • NovinoAI provides digital and AI solutions to support research and pharmaceutical collaboration for biomarker and drug discovery.

About Us

  • Pathologists with decades of clinical practice and track record of academic research.

  • Bioinformaticians and data scientists with years of experience in big data and AI fields

  • Computer software engineers with expertise in software and application development

  • Business entrepreneurs and regulatory attorneys to ensure business growth and compliance

bottom of page